Lung Chang
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 3
- Microbiology top 10%
-
- Respiratory viral infections research 7
- Pneumonia and Respiratory Infections 6
- Influenza Virus Research Studies 5
-
- Carbon and Quantum Dots Applications 7
- Advanced Nanomaterials in Catalysis 4
-
- Streptococcal Infections and Treatments 5
-
- Viral-associated cancers and disorders 3
Lung Chang
43 papers receiving 720 citations
Peers
Comparison fields: 5 of 103
- Infectious Diseases 248
- Microbiology 39
- Molecular Medicine 31
- Rehabilitation 30
- Epidemiology 149
Countries citing papers authored by Lung Chang
This map shows the geographic impact of Lung Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lung Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lung Chang more than expected).
Fields of papers citing papers by Lung Chang
This network shows the impact of papers produced by Lung Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lung Chang. The network helps show where Lung Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lung Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 16 | |
| 11 | 2021 | 4 | |
| 12 | 2018 | 35 | |
| 13 | 2017 | 8 | |
| 14 | 2017 | 8 | |
| 15 | 2017 | 13 | |
| 16 | 2016 | 1 | |
| 17 | 2015 | 32 | |
| 18 | 2013 | 9 | |
| 19 | 2013 | 20 | |
| 20 | 2011 | 7 |
About Lung Chang
Lung Chang is a scholar working on Infectious Diseases, Epidemiology, Microbiology, Modeling and Simulation and Molecular Medicine, having authored 46 papers that have together received 735 indexed citations. Recurring topics across this work include Respiratory viral infections research (7 papers), Carbon and Quantum Dots Applications (7 papers), Pneumonia and Respiratory Infections (6 papers), Influenza Virus Research Studies (5 papers), Streptococcal Infections and Treatments (5 papers), Advanced Nanomaterials in Catalysis (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Infectious Diseases (248 citations), Microbiology (39 citations), Molecular Medicine (31 citations), Rehabilitation (30 citations) and Epidemiology (149 citations). Lung Chang has collaborated with scholars based in Taiwan, United States and Canada. Frequent co-authors include Hsin Chi, Chih‐Ching Huang, Nan‐Chang Chiu, Daniel Tsung‐Ning Huang, H.‐J. Lin, Ju‐Yi Mao, Chin‐Jung Lin, Han‐Wei Chu, Binesh Unnikrishnan and Pei‐Ching Chang. Their work appears in journals such as Journal of Microbiology Immunology and Infection, Frontiers in Pediatrics, Small, Nanoscale and Journal of Colloid and Interface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.